Christian Idel

Title: The Innovative Contributions of Christian Idel

Introduction

Christian Idel is a notable inventor based in Chicago, IL (US). He has made significant strides in the field of cancer research through his innovative work on chimeric antigen receptors. His contributions are vital in the ongoing battle against cancer, showcasing the intersection of technology and medicine.

Latest Patents

Christian Idel holds a patent for "Chimeric antigen receptors recognizing cancer-specific TN glycopeptide variants." This patent discloses binding proteins that specifically target a cancer-specific glycosylation variant of a protein. These proteins can bind to a second epitope on the same protein or to different proteins presented on the same or different cells. The patent also includes polynucleotides encoding these binding proteins, which can be optimized for expression in specific host cells. Furthermore, it outlines methods for producing the encoded polypeptide and its application in treating, preventing, or alleviating cancer symptoms.

Career Highlights

Christian Idel is affiliated with the University of Chicago, where he continues to advance his research and innovation in cancer therapies. His work is characterized by a commitment to developing effective treatments that can significantly improve patient outcomes.

Collaborations

Christian collaborates with esteemed colleagues such as Hans Schreiber and Boris Engels. Their combined expertise enhances the research efforts and contributes to the development of groundbreaking therapies.

Conclusion

Christian Idel's innovative work in cancer research exemplifies the potential of targeted therapies in modern medicine. His patent and ongoing research efforts are crucial in the fight against cancer, paving the way for future advancements in treatment.